StockWatch
·
Pharmaceuticals
Regulatory3 Jul 2026, 12:49 pm

Colinz Laboratories: Regulation 32 Not Applicable for Q1 FY27

AI Summary

Colinz Laboratories Limited has informed the exchange that Regulation 32 of SEBI (LODR) Regulations, 2015, pertaining to the statement of deviation or variation for proceeds of public issue, rights issue, preferential issue, or QIP, is not applicable to the company for the quarter ended June 30, 2026. This is because the company has not undertaken any such fundraising activities during the period. The disclosure is made as per regulatory requirements.

Key Highlights

  • Regulation 32 of SEBI LODR is not applicable to Colinz Laboratories.
  • The company did not undertake any public, rights, or preferential issues.
  • This applies to the quarter ended June 30, 2026.
  • The company is complying with regulatory disclosure requirements.